Since the FDA approval of Gardasil 9 in late 2014, CPP members have been steadily converting from Gardasil to Gardasil 9 as the preferred HPV vaccine for their patients.
Effective October 31, 2016, Merck will no longer sell Gardasil. This decision is not related to any product safety or manufacturing issues with Gardasil and all existing inventories will be depleted. Any unused Gardasil doses can be returned to Merck for credit after their expiration date, in accordance with the Merck Return Policy.
Please note that GARDASIL® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) is available and is not impacted by this action.